Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy

Objective: This study is a comprehensive review of the clinical pharmacology, pharmacokinetics, efficacy, safety, and clinical applicability of amivantamab-vmjw for metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion (exon20ins) mutation. Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Vishal, McNatty, Andrea, Simpson, Lacey, Ofori, Henry, Raheem, Farah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046583/
https://www.ncbi.nlm.nih.gov/pubmed/36979929
http://dx.doi.org/10.3390/biomedicines11030950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046583/
https://www.ncbi.nlm.nih.gov/pubmed/36979929
http://dx.doi.org/10.3390/biomedicines11030950

Ejemplares similares